Beta-adrenoceptor-blocking agents: Are pharmacologic differences relevant?
- 1 August 1982
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 104 (2) , 334-346
- https://doi.org/10.1016/0002-8703(82)90124-7
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agentsAmerican Heart Journal, 1982
- Clinical pharmacology of pindololAmerican Heart Journal, 1982
- Hemodynamic Consequences of Long-Term Beta-Blocker TherapyJournal of Cardiovascular Pharmacology, 1979
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 5. Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospasmAmerican Heart Journal, 1979
- Comparison of β‐adrenoceptors mediating vasodilatation in canine subcutaneous adipose tissue and skeletal muscleActa Physiologica Scandinavica, 1978
- Long‐term Hypotensive Effect of Atenolol (ICI 66.082), a New β‐adrenergic Blocking AgentActa Medica Scandinavica, 1976
- HEMODYNAMIC CHANGES AT REST AND DURING EXERCISE IN LONG‐TERM β‐BLOCKER THERAPY OF ESSENTIAL HYPERTENSIONActa Medica Scandinavica, 1974
- Adverse Effects of ??-Adrenergic Receptor Blocking Drugs on Respiratory FunctionDrugs, 1974
- Differentiated blockade of the chronotropic effects of various adrenergic stimuli in the cat heartLife Sciences, 1972
- Differentiation of receptors responsive to isoproterenolLife Sciences, 1967